New therapeutic options of carcinoid syndrome metastatic to the liver.
Carcinoid syndrome is a relatively rare disease, generally associated with poor prognosis. Conventional diagnostic and therapeutic methods often prove inadequate and ineffective. New therapeutic options have recently been provided by Radiolabeled long-acting somatostatin analogs (Octreotide), alpha interferon, 131 MIBG and non-pharmacological methods--embolization of the hepatic artery, gene therapy, and combined therapies.
Wardyn
K A
KA
Department and Clinic of Internal Medicine and Nephrology, Department of Family Medicine, Medical University, Warsaw, Poland.
Zycińska
K
K
Oledzka-Oreziak
M
M
Ostrowski
K
K
Krawczyk
M
M
Królicki
L
L
Caplin
M
M
D019797:3-Iodobenzylguanidine / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D002276:Carcinoid Tumor / Q000473:pathology* / Q000601:surgery / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology; D008099:Liver / Q000473:pathology*; D008113:Liver Neoplasms / Q000556:secondary*; D009362:Neoplasm Metastasis; D013004:Somatostatin / Q000494:pharmacology
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D019797:3-Iodobenzylguanidine; D013004:Somatostatin